Bone morphogenetic proteins. A review for cranial and maxillofacial surgery

Oral and Maxillofacial Surgery Clinics of North America

Volumn 14, Issue 1, 2002, Pages 1-14

  Azari, Kodi ^a   Doctor, John S ^b,c   Doll, Bruce A ^b,d   Hollinger, Jeffrey O ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b CARNEGIE MELLON UNIVERSITY   (United States)

^c DUQUESNE UNIVERSITY   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN RECEPTOR; COLLAGEN; DNA BINDING PROTEIN; ENDOTHELIAL CELL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; FOLLISTATIN; GROWTH DIFFERENTIATION FACTOR 5; HEPARIN; NOGGIN; OSTEOGENIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR; PROTEIN SERINE THREONINE KINASE; PROTEOGLYCAN; SMAD PROTEIN; SOMATOMEDIN; THROMBOCYTE FACTOR 4; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BONE ALLOGRAFT; BONE DEVELOPMENT; BONE INJURY; BONE REGENERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CRANIOFACIAL MALFORMATION; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFICACY; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG STRUCTURE; ECCHYMOSIS; ENZYME ACTIVITY; FACE EDEMA; FRACTURE HEALING; GENE EXPRESSION; HUMAN; MALE; MAXILLOFACIAL SURGERY; MOUSE; MOUTH DISEASE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; POSTOPERATIVE CARE; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RHINITIS; SIGNAL TRANSDUCTION; SINUSITIS; SKULL SURGERY; STRUCTURE ANALYSIS;

EID: 0036334945     PISSN: 10423699     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1042-3699(02)00011-0     Document Type: Review

References (119)

1. Constitutively active BMP type I receptors transduce BMP-2 signals without the ligand in C2C12 myoblasts
2. Potent ectopic bone-inducing activity of bone morphogenetic protein-4/7 heterodimer
3. New treatment strategies for diabetic foot ulcers
4. From receptor to nucleus: The Smad pathway
5. Ridge augmentation following implantation of recombinant human bone morphogenetic protein-2 in the dog
6. Mammalian subtilisins: The long-sought dibasic processing endoproteases
7. Combinatorial signaling through BMP receptor IB and GDF5: Shaping of the distal mouse limb and the genetics of distal limb diversity
8. On myositis ossificans traumatica
9. Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing
10. Animal studies of application of rhBMP-2 in maxillofacial reconstruction
11. A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation
12. Gene-enhanced tissue engineering: Applications for bone healing using cultured periosteal cells transduced retrovirally with the BMP-7 gene
13. Evolution of the transforming growth factor-beta superfamily
14. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone
15. A transcriptional partner for MAD proteins in TGF-beta signalling
16. BMPs, Smads and metalloproteases: Extracellular and intracellular modes of negative regulation
17. Evaluation of recombinant human bone morphogenetic protein-2 in oral applications including the use of endosseous implants: 3-year results of a pilot study in humans
18. BMP-4 is proteolytically activated by furin and/or PC6 during vertebrate embryonic development
19. Distinct spatial and temporal expression patterns of two type I receptors for bone morphogenetic proteins during mouse embryogenesis
20. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye
21. Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation
22. Experimental induction of heterotopic bone
23. The dorsalizing and neural inducing gene follistatin is an antagonist of BMP-4
24. Mechanisms of GDF-5 action during skeletal development
25. Embryonic patterning: To BMP or not to BMP, that is the question
26. Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor
27. Efficient expression of a heterodimer of bone morphogenetic protein subunits using a baculovirus expression system
28. Expression pattern of osteogenic protein-1 (bone morphogenetic protein-7) in human and mouse development
29. TGF-beta signalling from cell membrane to nucleus through SMAD proteins
30. Bone morphogenetic proteins in development
31. Bone morphogenetic proteins: Multifunctional regulators of vertebrate development
32. The integrated processes of hard tissue regeneration with special emphasis on fracture healing
33. Poly(alpha-hydroxy acids): Carriers for bone morphogenetic proteins
34. A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation
35. The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities
36. Fibroblast growth factor and vascular endothelial factor families
37. Direct binding of follistatin to a complex of bone-morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo
38. Cloning of rat type I receptor cDNA for bone morphogenetic protein-2 and bone morphogenetic protein-4, and the localization compared with that of the ligands
39. Smad6 inhibits signalling by the TGF-beta superfamily
40. Involvement of Bone Morphogenetic Protein-4 (BMP-4) and Vgr-1 in morphogenesis and neurogenesis in the mouse
41. Signal transduction by bone morphogenetic proteins
42. Repair of calvarial defects with flap tissue: Role of bone morphogenetic proteins and competent responding tissues
43. Tissue transformation into bone in vivo: A potential practical application
44. What do BMPs do in mammals? Clues from the mouse short-ear mutation
45. The mouse short ear skeletal morphogenesis locus is associated with defects in a bone morphogenetic member of the TGF beta superfamily
46. Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1
47. Characterization of a bone morphogenetic protein-responsive Smad-binding element
48. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways
49. Smad2 and Smad3 positively and negatively regulate TGF beta-dependent transcription through the forkhead DNA-binding protein FAST2
50. The normal and pathological physiology of bone and its problems
51. Die Verwendung der freien Knochenplastik nebst Versuchen über Gelenkversteifung und Gelenk-transplantation
52. Bone morphogenetic proteins: Biology, biochemistry, reconstructive surgery
53. BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning
54. Colocalization of BMP 7 and BMP 2 RNAs suggests that these factors cooperatively mediate tissue interactions during murine development
55. Recombinant human bone morphogenetic protein-2 is superior to demineralized bone matrix in repairing craniotomy defects in rats
56. Maxillary sinus augmentation in the non-human primate: A comparative radiographic and histologic study between recombinant human osteogenic protein-1 and natural bone mineral
57. Spectrum of Bmp5 mutations from germline mutagenesis experiments in mice
58. TGF-beta signal transduction
59. Controlling TGF-beta signaling
60. Eighteen-month radiographic and histologic evaluation of sinus grafting with anorganic bovine bone in the chimpanzee
61. Residual lateral wall defects following sinus grafting with recombinant human osteogenic protein-1 or Bio-Oss in the chimpanzee
62. Bone morphogenetic proteins in the nervous systems
63. Preparation and characterization of the different types of collagen
64. A BMP-inducible gene, dlx5, regulates osteoblast differentiation and mesoderm induction
65. Estrogen opposes the apoptotic effects of bone morphogenetic protein 7 on tissue remodeling
66. Regulation of differentiation by TGF-beta
67. Dose-dependence of and threshold for optimal bone induction by collagenous bone matrix and osteogenin-enriched fraction
68. Activin-binding protein from rat ovary is follistatin
69. Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing
70. Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300
71. A kinase domain-truncated type I receptor blocks bone morphogenetic protein-2-induced signal transduction in C2C12 myoblasts
72. Fascia transplantation into visceral defects
73. Distinct and overlapping patterns of localization of bone morphogenetic protein (BMP) family members and BMP type II receptor during fracture healing in rats
74. Bone morphogenetic protein-15: Identification of target cells and biological functions
75. OP-1 cDNA encodes an osteogenic protein in the TGF-beta family
76. Osteogenic protein-2: A new member of the transforming growth factor-beta superfamily expressed early in embryogenesis
77. Teeth: Where and how to make them
78. Dorsoventral patterning in Xenopus: Inhibition of ventral signals by direct binding of chordin to BMP-4
79. Su neoformazioni cartilaginee ed osse determinate da innesti di frammenti di cartilagine e d'osso fissati
80. Regulation of cartilage and bone differentiation by bone morphogenetic proteins
81. Bone and cartilage differentiation
82. Bone and cartilage morphogenesis: Cell biology to clinical applications
83. Role morphogenetic proteins in skeletal tissue engineering and regeneration
84. Involvement of bone morphogenetic protein-4 and bone morphogenetic protein-7 in the differentiation of the adrenergic phenotype in developing sympathetic neurons
85. Application of purified bone morphogenetic (BMP) in cranio-maxillo-facial surgery. BMP in compromised surgical reconstructions using titanium implants
86. Latent transforming growth Factor-beta binding proteins (LTBPs): Structural extracellular matrix proteins for targeting TGF-beta action
87. Bone morphogenetic proteins: From basic studies to clinical approaches
88. Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a conserved family of transforming growth factor beta pathway components
89. Refined crystal structure of human transforming growth factor beta 2 at 1.95 A resolution
90. Bone morphogenetic proteins: An update on basic biology and clinical relevance
91. Mammalian BMP-1/Tolloid-related metalloproteinase, including novel family member mammalian Tolloid-like 2, have differential enzymatic and distributions of expression relevant to patterning and skeletogenesis
92. Genetic characterization and cloning of mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster
93. On healing of aseptic bone cavities by implantation of antiseptic decalcified bone
94. Mice lacking Bmp6 function
95. Limb alterations in brachypodism mice due to mutations in a new member of the TGF beta-superfamily
96. Regulation of epidermal induction by BMP2 and BMP7 signaling
97. A truncated bone morphogenetic protein receptor affects dorsal-ventral patterning in the early Xenopus embryo
98. Mandibular reconstruction with a recombinant bone-inducing factor: Functional histologic, and biomechanical evaluation
99. Bone: Formation by autoinduction
100. Bone morphogenetic protein and proteinase in the guinea pig
101. Human bone morphogenetic protein (hBMP)
102. Bone morphogenetic protein
103. Osteoclast function: Biology and mechanism
104. Osteogenesis in the interior of intramuscular implants of decalcified bone matrix
105. Allogeneic and xenogeneic bone morphogenetic protein in skeletal reconstruction
106. Purification and characterization of other distinct bone-inducing factors
107. Tissue-engineered bone biomimetic to regenerate calvarial critical-sized defects in athymic rats
108. Carrier system for bone morphogenetic proteins
109. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse
110. Bone morphogenetic proteins
111. The bone morphogenetic protein family and osteogenesis
112. Novel regulators of bone formation: Molecular clones and activities
113. Regulation of Smad activity
114. A distinct nuclear localization signal in the N terminus of Smad 3 determines its ligand-induced nuclear translocation
115. Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2)
116. Mice deficient for BMP2 are nonviable and defects in amnion/chorion and cardiac development
117. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription
118. A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia
119. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4